American journal of therapeuticsHumansSchizophreniaAntipsychotic AgentsAdultMuscarinic Agonists
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in Adults.
Ana Aliana Miron, Petru Iulian Ifteni, Timothy Nguyen, Lorena Dima
Published: 202510.1097/MJT.0000000000002026
Abstract
BACKGROUND: Schizophrenia is characterized by 3 main groups of symptoms: positive, negative, and cognitive. Traditional antipsychotics primarily address positive symptoms via dopamine D2 receptor blockade but often cause side effects like movement di…
Preview only. Read the full abstract at the source